Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 15/20 | 0.40 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.32 |
| ▸ | GUCY1B2 | O75343 | 2/20 | 0.32 |
| ▸ | GUCY1A2 | P33402 | 2/20 | 0.32 |
| ▸ | GUCY1A1 | Q02108 | 2/20 | 0.32 |
| ▸ | GUCY1B1 | Q02153 | 2/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP3 | P08254 | 1/20 | 0.32 |
| ▸ | MMP7 | P09237 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16412321 | 0.88 | FAAH (0.39) | FAAHCXCR3 | |
| SCHEMBL15230545 | 0.88 | FAAH (0.39) | FAAHALDH1A1 | |
| SCHEMBL15230849 | 0.86 | FAAH (0.41) | FAAHCXCR3 | |
| SCHEMBL15230607 | 0.85 | FAAH (0.41) | FAAH | |
| SCHEMBL15230625 | 0.82 | FAAH (0.46) | FAAH | |
| SCHEMBL15230099 | 0.81 | FAAH (0.40) | FAAH | |
| SCHEMBL15230718 | 0.80 | FAAH (0.40) | FAAH | |
| SCHEMBL15231469 | 0.80 | FAAH (0.42) | FAAHCXCR3 | |
| SCHEMBL15230442 | 0.79 | FAAH (0.38) | FAAH | |
| SCHEMBL15231666 | 0.77 | GAA (0.36) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160007606-A1 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2016-01-14 | — | — | US | disclosed |
| EP-2820012-A1 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | Syngenta Participations AG (CH) | 2015-01-07 | — | — | EP | disclosed |
| WO-2013127784-A1 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2013-09-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160007606-A1 | MICROBIOCIDAL PYRAZOLE DERIVATIVES | PRF1, CASP1, MPO | FAAH 788/4885CXCR3 451/4885GUCY1B2 1617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.